Both in Surgical Instruments
LeMaitre Vascular vs NovoCure Limited
Over the past year LMAT returned −3.0% and NVCR returned +23.8%; their daily moves had a correlation of 0.06.
LMAT −3.0% NVCR +23.8%Growth of $1, one year, split-adjusted
| Metric | LMAT | NVCR |
|---|---|---|
| Price | $82.89 | $15.99 |
| Market cap | $1.90B | $1.86B |
| Today | +0.67% | +1.01% |
| 1 month | +3.0% | −10.3% |
| 6 months | −22.4% | +54.3% |
| Year to date | +2.2% | +23.7% |
| 1 year | −1.5% | +24.0% |
| Revenue growth (YoY) | +9.6% | +15.6% |
| Gross margin | 72.1% | 77.6% |
| Net margin | 24.2% | −8.5% |
| P/E (TTM) | 28.9× | — |
| Price / sales | 7.2× | 2.7× |
| Net cash | $207.1M | $244.7M |
| Dividend yield | 1.21% | — |
| Volatility (60d) | 64.5% | 74.6% |
| Short % of float | 8.0% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).